glp 1 agonist retatrutide 40mg What Is Retatrutide? The Triple

Doubling the receptor load makes them potentially unmanageable

Research on the effects of GLP1Ra-based therapies on the skeletal system are still emerging

GLP-1 agonists were initially approved for treating type 2 diabetes, with subsequent approvals for chronic weight management and reduction of the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 diabetes

Notably, genome-wide association study (GWAS) analyses for body mass index (BMI) have linked glutamatergic signalling and NMDA receptor-related neuroplasticity to regulation of body weight and obesity 1,5

Am J Physiol Renal Physiol (2009) 297(6):F164755

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study